Collaboration and commercialization fuels discovery. We forge global alliances across biopharma, vaccine development, gene therapy and advanced therapeutics to deliver affordable, high-impact health innovations & technologies.
Our mission is to accelerate R & D Science to translational medicines for equitable access to life-saving biologics and speciality products worldwide.
Platform Technology
Strategic Alliance
ABSNOVACELL, in partnership with ABS Inc. USA, is advancing the proprietary NOVACELL™ Vaccine Platform Technology — a next-generation system designed to produce highly efficacious, scalable and cost-effective vaccines with duarability.
Current platforms often introduce mutations in the HA region, leading to reduced efficacy. In contrast, AI/ML integrated with NOVACELL offer precise immunogenicity.
This global vaccine alliance integrates cutting-edge process science, GMP manufacturing and regulatory excellence to support the rapid and affordable delivery of vaccines to both developed and emerging markets.
Together, we are redefining vaccine accessibility through technology transfer, local production, regional clinical studies and collaborative global supply chains.
Advanced Therapeutics
Expanding from vaccines to advanced therapeutics, ABSNOVACELL is in active collaboration and negotiation with the U.S. companies, Saudi Arabia companies with middile east and Asian companies to deploy its proprietary Gene Therapy, Gene Editing and Advanced Biologics Platforms.
These partnerships focus on Next-gen AAV-based gene therapy, gene editing for rare disease treatment and technology transfer initiatives that bring curative solutions closer to patients.
Our goal: to make gene therapy accessible, affordable and sustainable, empowering new regional centers of excellence in regenerative medicine.
Expanding Horizons
in Advanced Therapeutics
NOVACELLBIO
Partnership
GMP-grade quality & ISO-certified production Tailored solutions across R&D, translational, and commercial scale Dedicated PhD-level scientific support Global logistics & supply chain integration Regulatory-ready documentation for IND, NDA, or CE-IVD.
For More Products https://novacellbio.com/
Advanced Therapeutics
We are actively seeking strategic partners, investors and biopharma collaborators who share our mission to democratize access to next-generation health technologies.
By partnering with ABSNOVACELL, you gain access to:
Proven vaccine , biologics and cell & gene - therapy platforms
Deep regulatory and manufacturing expertise
A network of global collaborators across the U.S., India, Europe and the Middle East
A shared vision of affordability, accessibility and innovation
Partnership
In a groundbreaking Swiss natural cosmetics joint venture, ABSNOVACELL has partnered with SPC Super Specialty Natural Cosmetics (SPC, Switzerland).
This commercial JV combines Swiss precision, sustainable innovation to create a new generation of clinically validated, naturally derived high quality cosmetic and dermatological products.
Through this partnership, we’re redefining the intersection of biotechnology and natural beauty, delivering safe, high-performance formulations built on science, sustainability and consumer trust.
Partner with us to shape the future of biologics and Next-Gen therapeutics — delivering better health, sustainably, affordability to every corner of the world.